Universidad de la Salle, VU Medical Center

Assistant Professor of Medicine
Nephrology and Hypertension

Professional Bio

Juan Pablo (JP for short), was born and raised in Mexico City, Mexico. During the the last year of medical school he began a life-long affair with the kidney! This led JP to pursue a Ph.D. in renal physiology, with a focus on how salt impacts blood pressure. Upon completing his Ph.D., JP moved to New Haven CT, where JP completed an intern year in General – Surgery at Yale-New Haven Hospital, as well as a two-year post-doc focusing on the molecular mechanisms of renal salt reabsorption. He is incredibly excited to continue his training in Medicine and Nephrology at Vanderbilt. 


MD - Universidad La Salle - 2009
PhD - UNAM, México - 2012
Internship - General Surgery - Yale New Haven Hospital - 2013
Residency - Internal Medicine - Vanderbilt University Medical Center - 2017
Residency - Chief Resident - Vanderbilt University Medical Center - 2019
Fellowship - Genetics and Hypertension - Yale University - 2015
Fellowship - Nephrology - Vanderbilt University Medical Center - 2018
Fellowship - Nephrology - Vanderbilt University Medical Center - 2020


Arroyo JP, Johnson DC, Lewis JB, Al Sheyyab A, King A, Danter MR, McGrane S, Fessel JP. Treatment of Acute Intoxication with Inhaled 1,2-Difluoroethane. Ann Int Med 2018 IN PRESS

Arroyo JP, Zhu L, Dee K, Concepcion BP. Painful erythematous skin nodules in a kidney transplant recipient. Am J Transplant. 2018 Jan;18(1):268-270. doi: 10.1111/ajt.14551

Edmonds PJ, Arroyo JP, Morales A, Brown RM, Ely EW. Intrahepatic Pancreatic Pseudocyst: a Rare  Complication of Pancreatitis. J Gastrointestin Liver Dis. 2017 26:3, 222. doi.org/10.15403/jgld.2014.1121.263.pje

Anand M*, Arroyo JP*, Alhalabi H, Thayer T, Lusco M, Langone B, Concepcion B. IgA-Dominant Glomerulonephritis Presenting as Acute Renal Failure in a Kidney Transplant Recipient

Pandey AK, Singhi EK, Arroyo JP, Ikizler TA, Gould ER, Brown J, Beckman JA, Harrison DG, Moslehi J. Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease. Hypertension. 2017 Dec 26. Doi: 10.1161/HYPERTENSIONAHA.117110271. (In Press)